Prostaglandin E2-EP2-NF-κB signaling in macrophages as a potential therapeutic target for intracranial aneurysms

被引:162
作者
Aoki, Tomohiro [1 ,2 ]
Frosen, Juhana [3 ,4 ,5 ]
Fukuda, Miyuki [1 ]
Bando, Kana [6 ,7 ]
Shioi, Go [7 ]
Tsuji, Keiichi [8 ]
Ollikainen, Eliisa [3 ]
Nozaki, Kazuhiko [8 ]
Laakkonen, Johanna [9 ]
Narumiya, Shuh [1 ,2 ]
机构
[1] Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto 6068501, Japan
[2] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, Core Res Evolut Sci & Technol, Kyoto 6068507, Japan
[3] Biomedicum Helsinki, Neurosurg Res Grp, Helsinki 00029, Hus, Finland
[4] Kuopio Univ Hosp, NeuroCtr, Hemorrhag Brain Pathol Res Grp, Kuopio 70029, Kys, Finland
[5] Kuopio Univ Hosp, NeuroCtr, Dept Neurosurg, Kuopio 70029, Kys, Finland
[6] RIKEN, Ctr Life Sci Technol, Anim Resource Dev Unit, Kobe, Hyogo 6500047, Japan
[7] RIKEN, Ctr Life Sci Technol, Genet Engn Team, Kobe, Hyogo 6500047, Japan
[8] Shiga Univ Med Sci, Dept Neurosurg, Otsu, Shiga 5202192, Japan
[9] Univ Eastern Finland, AI Virtanen Inst, Dept Mol Med, Kuopio 70211, Finland
基金
日本科学技术振兴机构;
关键词
NF-KAPPA-B; CEREBRAL ANEURYSMS; SUBARACHNOID HEMORRHAGE; CHRONIC INFLAMMATION; RECEPTOR ANTAGONIST; RUPTURE; WALL; ACTIVATION; ASPIRIN; CELLS;
D O I
10.1126/scisignal.aah6037
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
Intracranial aneurysms are common but are generally untreated, and their rupture can lead to subarachnoid hemorrhage. Because of the poor prognosis associated with subarachnoid hemorrhage, preventing the progression of intracranial aneurysms is critically important. Intracranial aneurysms are caused by chronic inflammation of the arterial wall due to macrophage infiltration triggered by monocyte chemoattractant protein-1 (MCP-1), macrophage activation mediated by the transcription factor nuclear factor kappa B (NF-kappa B), and inflammatory signaling involving prostaglandin E-2 (PGE(2)) and prostaglandin E receptor subtype 2 (EP2). We correlated EP2 and cyclooxygenase-2 (COX-2) with macrophage infiltration in human intracranial aneurysm lesions. Monitoring the spatiotemporal pattern of NF-kappa B activation during intracranial aneurysm development in mice showed that NF-kappa B was first activated in macrophages in the adventitia and in endothelial cells and, subsequently, in the entire arterial wall. Mice with a macrophage-specific deletion of Ptger2 (which encodes EP2) or macrophage-specific expression of an I kappa B alpha mutant that restricts NF-kappa B activation had fewer intracranial aneurysms with reduced macrophage infiltration and NF-kappa B activation. In cultured cells, EP2 signaling cooperated with tumor necrosis factor-alpha (TNF-alpha) to activate NF-kappa B and synergistically induce the expression of proinflammatory genes, including Ptgs2 (encoding COX-2). EP2 signaling also stabilized Ccl2 (encoding MCP-1) by activating the RNA-stabilizing protein HuR. Rats administered an EP2 antagonist had reduced macrophage infiltration and intracranial aneurysm formation and progression. This signaling pathway in macrophages thus facilitates intracranial aneurysm development by amplifying inflammation in intracranial arteries. These results indicate that EP2 antagonists may therefore be a therapeutic alternative to surgery.
引用
收藏
页数:17
相关论文
共 59 条
[1]
In vitro and in vivo characterization of PF-044189948, a novel, potent and selective prostaglandin EP2 receptor antagonist [J].
af Forselles, K. J. ;
Root, J. ;
Clarke, T. ;
Davey, D. ;
Aughton, K. ;
Dack, K. ;
Pullen, N. .
BRITISH JOURNAL OF PHARMACOLOGY, 2011, 164 (07) :1847-1856
[2]
Flow detection and calcium signalling in vascular endothelial cells [J].
Ando, Joji ;
Yamamoto, Kimiko .
CARDIOVASCULAR RESEARCH, 2013, 99 (02) :260-268
[3]
PGE2-EP2 signalling in endothelium is activated by haemodynamic stress and induces cerebral aneurysm through an amplifying loop via NF-κB [J].
Aoki, T. ;
Nishimura, M. ;
Matsuoka, T. ;
Yamamoto, K. ;
Furuyashiki, T. ;
Kataoka, H. ;
Kitaoka, S. ;
Ishibashi, R. ;
Ishibazawa, A. ;
Miyamoto, S. ;
Morishita, R. ;
Ando, J. ;
Hashimoto, N. ;
Nozaki, K. ;
Narumiya, S. .
BRITISH JOURNAL OF PHARMACOLOGY, 2011, 163 (06) :1237-1249
[4]
Simvastatin suppresses the progression of experimentally induced cerebral aneurysms in rats [J].
Aoki, Tomohiro ;
Kataoka, Hiroharu ;
Ishibashi, Ryota ;
Nozaki, Kazuhiko ;
Hashimoto, Nobuo .
STROKE, 2008, 39 (04) :1276-1285
[5]
NF-κB is a key mediator of cerebral aneurysm formation [J].
Aoki, Tomohiro ;
Kataoka, Hiroharu ;
Shimamura, Munehisa ;
Nakagami, Hironori ;
Wakayama, Kouji ;
Moriwaki, Takuya ;
Ishibashi, Ryota ;
Nozaki, Kazuhiko ;
Morishita, Ryuichi ;
Hashimoto, Nobuo .
CIRCULATION, 2007, 116 (24) :2830-2840
[6]
Critical role of TNF-alpha-TNFR1 signaling in intracranial aneurysm formation [J].
Aoki, Tomohiro ;
Fukuda, Miyuki ;
Nishimura, Masaki ;
Nozaki, Kazuhiko ;
Narumiya, Shuh .
ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2014, 2
[7]
Prostaglandins and chronic inflammation [J].
Aoki, Tomohiro ;
Narumiya, Shuh .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2012, 33 (06) :304-311
[8]
The Development and the Use of Experimental Animal Models to Study the Underlying Mechanisms of CA Formation [J].
Aoki, Tomohiro ;
Nishimura, Andmasaki .
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2011,
[9]
Targeting chronic inflammation in cerebral aneurysms: focusing on NF-κB as a putative target of medical therapy [J].
Aoki, Tomohiro ;
Nishimura, M. .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2010, 14 (03) :265-273
[10]
Impact of Monocyte Chemoattractant Protein-1 Deficiency on Cerebral Aneurysm Formation [J].
Aoki, Tomohiro ;
Kataoka, Hiroharu ;
Ishibashi, Ryota ;
Nozaki, Kazuhiko ;
Egashira, Kensuke ;
Hashimoto, Nobuo .
STROKE, 2009, 40 (03) :942-951